Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer-Reference-Cited by-同舟云学术

Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer

Published:2018-04-26 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Park Byoung¹,Park Jae-Young²,Kim Te³,Kim Dongbum¹,Wu Guang¹,Gautam Avishekh³,Maharjan Sony¹,Lee Su¹,Lee Younghee⁴,Kwon Hyung-Joo¹^ORCID,Choi Kyung¹

Affiliation:

1. Center for Medical Science Research, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea

2. Department of Pathology, Hallym University Sacred Heart Hospital, Chuncheon 24253, Republic of Korea

3. Department of Microbiology, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea

4. Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance;Pharmaceuticals;2023-01-11

2. Identification of hub genes and key pathways in pediatric Crohn’s disease using next generation sequencing and bioinformatics analysis;2022-07-28

3. Targeting TM4SF5 with anti‑TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells;Oncology Letters;2019-11-21

4. Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex;BMB Reports;2019-06-30

5. Clinicopathological significance of TM4SF5 expression in human hepatocellular carcinoma tissues;Oncology Letters;2019-04-03